#COVID19 Webinar Series Session 1 (COVID-19 &Hematology Patient Care) - Addressing most urgent key questions for cancer patient care in coronavirus crisis.
Featuring an expert panel from Italy, Spain and Germany, EHA together with EBMT address urgent questions relating to cancer #patientcare during the #coronavirus crisis, in this first webinar session.
What are the current treatments for patients with hematological disease and COVID-19? Has there been a particular increase in the incidents of COVID-19 infections in patients who underwent an intensive chemotherapy program? What advise can they share with regards to preventing COVID-19 from spreading to health care staff, and what recommendations do they have on how to be well-prepared in your respective centers?
Tune in and learn from the 4 experts, who will be sharing their experiences in treating hematology patients undergoing intensive treatment, in this current crisis.
Speaker panel:
• Prof Alessandro Rambaldi (U.O. Ematologia, ASST Papa Giovanni XXIII, Bergamo, Italy)
• Prof Jose M Ribera (Josep Carreras Leukemia Research Institute, Barcelona, Spain)
• Prof Dr Marie von Lilienfeld-Toal (Universitätsklinikum Jena, Germany)
• Prof Malgorzata Mikulska (University of Genova, Italy)
This is a first, in a series of webinars looking at the care of hematology patients during the COVID-19 crisis. Visit
https://ehaweb.org/covid-19/webinars/, for more information on our upcoming webinars (details coming soon).
#EHACOVID19 #hematology